Clinical Advances in Prostate Cancer From ESMO 2021 Clinical Advances in Prostate Cancer From ESMO 2021

Prof Johann de Bono discusses prostate cancer data from ESMO 2021, including abiraterone plus prednisolone in nonmetastatic disease, two key trials in the metastatic setting, and 177Lu-PSMA-617.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news